Trial tests new drug duo in fight against spreading liver cancer
NCT ID NCT04828486
Summary
This study tested a combination of two drugs, futibatinib and pembrolizumab, in patients with a specific type of advanced liver cancer that had spread. The goal was to see if this combination could stop or slow the cancer's growth and extend the time patients lived without their disease getting worse. The trial involved 14 patients whose cancer had progressed after initial treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.